据悉，实验室将聚焦中药材及中成药质量标准体系建设、关键检测技术研发、高附加值产品创制及国际 认证路径探索，推动黑龙江中药标准与澳门及国际相关技术规范的衔接互认，探索"研发—认证—市 场"协同发展模式。 澳门大学副校长徐建表示，学校长期积极推动中医药质量标准研究、检测技术创新与国际对接。联合实 验室的成立，有助于进一步整合澳门与黑龙江两地的科研与产业资源，促进中药质量评价体系建设及成 果转化，服务中医药产业高质量发展。 黑龙江省中医药科学院副院长代表宁夏表示，黑龙江省拥有丰富的中药资源和坚实的产业基础。实验室 首要目标是成为国际标准攻坚"先锋站"，并成为高附加值中药健康产品"策源地"和高水准人才汇聚与培 养的"孵化器"。(完) 中新网澳门2月4日电 (记者 郑嘉伟)澳门大学与黑龙江省中医药科学院3日在澳门大学澳门中药检测中心 成立"龙药质量认证与产品创新联合实验室"(下称"实验室")，推动内地中药资源和澳门标准制定有效对 接。 2月3日，澳门大学与黑龙江省中医药科学院在澳门大学澳门中药检测中心成立"龙药质量认证与产品创 新联合实验室"。(澳门大学 供图) ...

Core Insights - The launch of the "Forging Era Managers" leadership training program marks a significant step in the company's talent development strategy aimed at enhancing management capabilities and driving business breakthroughs [1][8] Group 1: Training Program Overview - The training program is designed for 90 mid-level managers and core talent from various business units, focusing on upgrading skills to meet new challenges in strategic vision, operational capability, innovative thinking, and execution efficiency [1][3] - The program includes four core modules: strategic management, business thinking, marketing innovation, and operational analysis, with a total of ten key courses tailored to the practical needs of mid-level managers [5] Group 2: Leadership Expectations - The company emphasizes the need for managers to adopt a proactive mindset, embrace change, and enhance their capabilities through continuous learning and practical application [3][6] - The leadership encourages a culture of striving for excellence, urging managers to focus on creating value and overcoming challenges collaboratively [6][8] Group 3: Industry Context - The traditional Chinese medicine industry is at a critical juncture of inheritance and innovation, facing demands for digital transformation and heightened industry standards [5] - The training initiative is aligned with the company's goals for high-quality development, aiming to build a strong management team capable of meeting these evolving industry requirements [5][8]

（派特灵实验室） （中国HPV防治方案持续获得国际关注） 派特灵聚焦HPV转阴率，立足感染源头防治 据了解，派特灵长期以来始终将转阴率作为品牌研发与服务的重点。相较于HPV病毒可能引发的各类疾病，品 牌更专注于从感染源头进行干预。在持续优化产品转阴效果的同时，派特灵也积极探索应用场景的拓展。近年 来，品牌联合多家医院与临床专家，开展中西医结合防治路径的探索，一方面依托现代医学的疫苗与筛查体 系，另一方面发挥中医药"标本兼治"的特色，并结合其具有剥脱病毒寄生细胞等作用等专利技术，为临床医生 和感染者提供更多选择。 新年伊始，企业纷纷公布年度发展规划。近日，中药制剂品牌派特灵宣布，新一年将围绕"提升HPV转阴率"这 一核心目标，全面优化服务质量。该品牌在HPV病毒防治领域已有三十余年积累，随着HPV及宫颈癌防治知识 普及，其相关工作日益受到公众关注，并在国际学术会议上作为"中国方案"得到多国专家学者的研讨。 派特灵聚焦HPV转阴率，助力补全防治链路 根据规划，新一年派特灵在科研方面的投入，除持续优化产品体验与开发潜力外，还将着力于助力弥补HPV感 染防治链条中的薄弱环节，例如疫苗保护不全、筛查不及时、感染者心理负 ...

当中医药遇上人工智能，发展潜力有多大？ 专访省政协委员、省中医药管理局局长田兴军 省政协委员田兴军 今年，一台被称为"中医CT"的中医经络检测仪走进省两会现场，吸引了不少代表委员前去体验。 四川是中医药大省，素有"中医之乡、中药之库""无川药不成方"的美誉。今年的省政府工作报告提出， 建好用好国家中医药综合改革示范区，推进中医药事业产业文化"三位一体"高质量发展。"十五五"开局 之年，四川中医药将如何高质量发展？老百姓又能从中获得哪些实惠？2月2日，华西都市报、封面新闻 记者专访了省政协委员，四川省中医药管理局党组书记、局长田兴军。 拥抱科技 中医药在AI领域大有可为 四川省中医药管理局正会同省医保局，在国家试点基础上，结合本省实际，制定四川省中医优势病种按 病种付费目录，遵循"中医优势明显、诊疗路径清晰、费用相对稳定"原则，优先纳入具有中医特色的病 种，如桡骨远端骨折、踝关节扭伤等，并动态调整病种范围。通过医保支付方式改革，推动中医医疗机 构优化服务流程，降低群众就医负担，同时激励中医药特色技术传承创新。 下一步，两部门将进一步完善配套政策，明确中医优势病种的诊断标准、疗效评价指标和医保支付标 准，探索中医 ...

Group 1 - The "Global Traditional Chinese Medicine Culture Festival" will officially open on February 4 at the Beijing Phoenix Center, coinciding with the traditional Chinese solar term "Lichun," symbolizing the revival of life and the integration of traditional Chinese medicine (TCM) into global health narratives [1][2] - The festival is co-hosted by Phoenix TV and Dong'e Ejiao, focusing on the theme "TCM Going Global," aiming to deeply integrate TCM culture with modern technology and art [1][2] - The event will feature three core segments, including interactive experiences, thematic discussions, and a tribute ceremony, showcasing the global presence and cultural vitality of TCM [1][3] Group 2 - Five TCM cultural promoters from around the world will be honored at the festival, including figures from the United States, Malaysia, Iran, Italy, and Mali, each contributing to the promotion and integration of TCM with modern science and culture [3] - The festival has received strong support from various organizations, including the Hong Kong Center for the TCM industry chain, the France-China TCM Center, and the United Nations Global Compact's "Belt and Road" action platform [3] Group 3 - A pre-event live broadcast titled "Chatting with Friends of TCM" will take place on February 4 at 15:30, featuring special guests who will engage in light discussions and answer questions from the audience [4]

Core Viewpoint - The Guangzhou Pharmaceutical Group is entering a new phase of brand development with the establishment of the Brand Strategy Committee, focusing on a comprehensive brand strategy for the next five years [1]. Group 1: Brand Strategy and Management - The brand strategy framework is centered around "1+6," where "1" represents a unified brand strategy plan and "6" signifies six key strategic initiatives [1]. - The establishment of the Brand Strategy Committee marks a significant step in the company's brand construction efforts [1]. Group 2: Business Performance and Growth - The company aims to double its business performance, with key strategies including regional expansion and internationalization of technology innovation [4]. - The acquisition of Caishantang is highlighted as a successful case of regional expansion, achieving a fourfold revenue increase after expanding its market presence beyond Fujian Province [4]. Group 3: Scientific Research and Internationalization - The company emphasizes the importance of scientific research to validate the effectiveness of traditional Chinese medicine, aiming for international collaboration with research institutions in North America and Europe [5][6]. - Recent achievements include the publication of a product in a top international journal and the recognition of another product in Russia, showcasing the potential for traditional medicine to be integrated into global healthcare solutions [6]. Group 4: Strategic Partnerships and Capital Operations - Under the leadership of Li Xiaojun, the company has accelerated its capital operations and formed strategic partnerships, including a collaboration with Huawei to enhance its international strategy [7]. - The company has made significant investments in innovative drugs and high-end medical devices, with plans for substantial R&D and investment in the coming years [7]. Group 5: Policy Recommendations and Industry Development - Li Xiaojun has proposed measures to support the biopharmaceutical industry, including establishing a systematic error-correction mechanism and creating a global talent network [8]. - Recommendations also include developing a collaborative response mechanism for international trademark disputes to support companies venturing abroad [8].

Core Viewpoint - China is significantly advancing its traditional Chinese medicine (TCM) service system, establishing the world's largest traditional medicine service framework, with substantial growth in healthcare institutions and patient visits by the end of 2024 [1]. Group 1: Growth Metrics - By the end of 2024, the number of TCM healthcare institutions, hospitals, and total patient visits will have increased by 43.3%, 16.7%, and 58.9% respectively compared to the end of the 13th Five-Year Plan [1]. - The TCM service system is expanding in both capacity and quality, enhancing the supply of high-quality TCM services [1]. Group 2: Project Initiatives - In 2025, China will support 450 county-level TCM hospitals to develop the "two specialties and one center" project, further solidifying and expanding grassroots TCM services [1]. - An additional 90 national TCM specialty areas will be established, including mental health, pediatrics, and gynecology, along with the launch of 57 suitable TCM disease categories for payment by disease type [1]. Group 3: Collaborative Development - The establishment of flagship hospitals and departments for collaborative TCM and Western medicine will focus on major difficult diseases, with 212 clinical collaboration projects planned [1]. - In 2025, the first national artificial intelligence application pilot base for TCM diagnosis and treatment services will be built, alongside 12 pilot projects for "smart TCM" [1].

Group 1: Oil Tea Industry Development - The oil tea industry is being diversified to enhance its economic potential, with a focus on high-end skincare products [12][13] - The comprehensive utilization rate of oil tea fruit resources has increased from less than 20% to over 50% through technological advancements [13] - The initiative has led to an increase in annual income of over 20,000 yuan for more than 40,000 farming households [13] Group 2: Engineering Machinery Export - Hunan has initiated a remanufacturing system reform for engineering machinery, addressing legal and quality control challenges [14] - The province has saved over 85 million yuan in costs and reduced processing time by two months through innovative legal measures [14] - Over 3 billion yuan worth of remanufactured equipment has been exported from Hunan in the past two years [15] Group 3: Youth Talent Attraction - Hunan's "Wisdom Hunan, Talent Gathering" initiative has successfully attracted 43,000 job seekers from 235,000 resumes received [16] - The province offers substantial support for entrepreneurship, including three years of free office space and various financial incentives [16] - There are currently 425 entrepreneurial incubation bases in Hunan, with nearly 4,000 projects initiated by university students [16] Group 4: Minor Protection and Mental Health - A collaborative approach involving families, schools, and communities is being promoted to support the mental health of students [17] - A proposal for a coordinated care network for vulnerable children has been implemented, with support from multiple government departments [17] - The focus for the upcoming sessions will be on enhancing student safety through improved legal and community support mechanisms [17] Group 5: Straw Utilization for Rural Revitalization - The comprehensive utilization of straw is seen as a key ecological and economic strategy for rural areas [18] - Hunan produces over 36 million tons of straw annually, with initiatives in place to reduce environmental impact and enhance farmer income [18] - The province has established 1,195 collection points and 1,372 utilization entities to promote diverse applications of straw [18] Group 6: Hunan-Hong Kong Cooperation - Efforts are being made to strengthen economic ties between Hunan and Hong Kong, focusing on sectors like traditional Chinese medicine and finance [19] - A recent exchange led to six enterprises signing agreements, showcasing the potential for collaboration [19] - The ongoing strategy aims to facilitate the integration of resources, technology, and talent between the two regions [20]

转自：南京晨报 近日，江苏省卫生健康委员会、江苏省中医药管理局正式公布《江苏省高水平中医药重点学科建设项 目》入选名单。江苏省第二中医院（南京中医药大学第二附属医院）肛肠科牵头申报的"中西医结合肠 道微生态学"成功获批江苏省高水平中医药重点学科建设项目，这也是该项目建设名单中少有的交叉创 新类重点学科。 三十载深耕 孕育交叉创新硕果 "中西医结合肠道微生态学"是江苏省第二中医院在肛肠科深厚基础上，顺应医学发展趋势孕育催生的新 兴交叉学科。据悉，该院肛肠科成立于1988年，2022年成为江苏省省级中医重点专科建设单位。学科发 展历经了从肛肠疾病临床诊疗，到聚焦肠道微生态在疾病中的作用探索，再到系统构建中西医结合研究 体系三个阶段。 该学科带头人、该院肛肠科主任金黑鹰介绍，肠道菌群和人体健康息息相关，也和药物是否起效具有很 多关联。科室从2018年前后开始使用肠道菌群移植来治疗众多肠道疾病，目前已经开展300余例治疗， 随着研究的逐步进展，发现肠道菌群对难治性的代谢性疾病、肿瘤患者耐药等领域也有作用。 金黑鹰说，之所以强调中西医结合，是因为肠道菌群治疗疾病最早记录在东汉时期的《肘后急备方》 中，到《本草纲目》中已 ...

近日，江苏省卫生健康委员会、江苏省中医药管理局正式公布《江苏省高水平中医药重点学科建设项 目》入选名单。江苏省第二中医院肛肠科申报的"中西医结合肠道微生态学"成功入选交叉创新类重点学 科，标志着医院在中西医交叉学科建设领域实现重大突破，正式跻身全省中医药重点学科建设行列。 转自：扬子晚报 通讯员 葛妍 许倩倩 校对 陶善工 据悉，"中西医结合肠道微生态学"是江苏省第二中医院在肛肠科深厚基础上，顺应医学发展趋势孕育催 生的新兴交叉学科。学科带头人、该院肛肠科主任金黑鹰介绍，肠道菌群和人体健康息息相关，也和药 物是否起效具有很多关联。科室从2018年前后开始使用肠道菌群移植来治疗众多肠道疾病，目前已经开 展300余例治疗，随着研究的逐步进展，发现肠道菌群对难治性的代谢性疾病、肿瘤患者耐药等领域也 有作用。 金黑鹰表示，之所以强调中西医结合，是因为肠道菌群治疗疾病最早记录在东汉时期的《肘后急备方》 到后来的《本草纲目》，都已经有较为系统的介绍。"现代除了利用肠道菌群移植的方式，还可在肠道 菌群中融入各类中药辅助改善患者的状况或提升疗效。"他介绍，学科建设将重点从肠道微生态对靶向 药、抗体药和免疫治疗药物敏感性的影响 ...